153 related articles for article (PubMed ID: 1350264)
1. Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.
de Saint Basile G; Notarangelo LD; Bonaiti-Pellié C; Doussau M; Prolini O; Craig IW; Ugazio A; Griscelli C; Fischer A
Hum Genet; 1992 May; 89(2):223-8. PubMed ID: 1350264
[TBL] [Abstract][Full Text] [Related]
2. Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.
Goodship J; Carter J; Espanol T; Boyd Y; Malcolm S; Levinsky RJ
Blood; 1991 Jun; 77(12):2677-81. PubMed ID: 2043768
[TBL] [Abstract][Full Text] [Related]
3. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect.
Greer WL; Kwong PC; Peacocke M; Ip P; Rubin LA; Siminovitch KA
Genomics; 1989 Jan; 4(1):60-7. PubMed ID: 2563352
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetic diagnosis of Wiskott-Aldrich syndrome].
Orth U; Rosenkranz W; Schwinger E; Holzgreve W; Gal A
Monatsschr Kinderheilkd; 1993 Sep; 141(9):728-31. PubMed ID: 8413349
[TBL] [Abstract][Full Text] [Related]
5. Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.
Notarangelo LD; Parolini O; Porta F; Locatelli F; Lanfranchi A; Marconi M; Nespoli L; Albertini A; Craig IW; Ugazio AG
Hum Genet; 1991 Dec; 88(2):237-41. PubMed ID: 1684569
[TBL] [Abstract][Full Text] [Related]
6. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus.
Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW
Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703
[TBL] [Abstract][Full Text] [Related]
7. Carrier detection in the Wiskott Aldrich syndrome.
Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
[TBL] [Abstract][Full Text] [Related]
8. Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3.
Kwan SP; Lehner T; Hagemann T; Lu B; Blaese M; Ochs H; Wedgwood R; Ott J; Craig IW; Rosen FS
Genomics; 1991 May; 10(1):29-33. PubMed ID: 1675197
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.
Hendriks RW; De Weers M; Mensink RG; Kraakman ME; Mollee-Versteegde IF; Veerman AJ; Sandkuyl LA; Schuurman RK
Clin Exp Immunol; 1991 May; 84(2):219-22. PubMed ID: 1709069
[TBL] [Abstract][Full Text] [Related]
10. Application of molecular analysis to genetic counseling in the Wiskott-Aldrich syndrome (WAS).
Notarangelo LD; Candotti F; Parolini O; Mantuano E; Giliani S; Lanfranchi A; Albertini A
DNA Cell Biol; 1993 Sep; 12(7):645-9. PubMed ID: 8397823
[TBL] [Abstract][Full Text] [Related]
11. Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome.
Arveiler B; de Saint-Basile G; Fischer A; Griscelli C; Mandel JL
Am J Hum Genet; 1990 May; 46(5):906-11. PubMed ID: 1971143
[TBL] [Abstract][Full Text] [Related]
12. Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome.
de Saint Basile G; Arveiler B; Fraser NJ; Boyd Y; Graig IW; Griscelli G; Fischer A
Lancet; 1989 Dec; 2(8675):1319-21. PubMed ID: 2574264
[TBL] [Abstract][Full Text] [Related]
13. X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.
De Saint-Basile G; Schlegel N; Caniglia M; Le Deist F; Kaplan C; Lecompte T; Piller F; Fischer A; Griscelli C
Ann Hematol; 1991 Aug; 63(2):107-10. PubMed ID: 1912030
[TBL] [Abstract][Full Text] [Related]
14. Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction.
Greer WL; Mahtani MM; Kwong PC; Rubin LA; Peacocke M; Willard HF; Siminovitch KA
Hum Genet; 1989 Oct; 83(3):227-30. PubMed ID: 2571560
[TBL] [Abstract][Full Text] [Related]
15. The Wiskott-Aldrich syndrome: refinement of the localization on Xp and identification of another closely linked marker locus, OATL1.
Greer WL; Peacocke M; Siminovitch KA
Hum Genet; 1992 Feb; 88(4):453-6. PubMed ID: 1346773
[TBL] [Abstract][Full Text] [Related]
16. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.
Fey MF; Peter HJ; Hinds HL; Zimmermann A; Liechti-Gallati S; Gerber H; Studer H; Tobler A
J Clin Invest; 1992 May; 89(5):1438-44. PubMed ID: 1349026
[TBL] [Abstract][Full Text] [Related]
17. Variable X-chromosome DNA methylation patterns detected with probe M27 beta in a series of lymphoid and myeloid malignancies.
Hodges E; Howell WM; Boyd Y; Smith JL
Br J Haematol; 1991 Mar; 77(3):315-22. PubMed ID: 2012755
[TBL] [Abstract][Full Text] [Related]
18. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers.
Kwan SP; Sandkuyl LA; Blaese M; Kunkel LM; Bruns G; Parmley R; Skarshaug S; Page DC; Ott J; Rosen FS
Genomics; 1988 Jul; 3(1):39-43. PubMed ID: 2906042
[TBL] [Abstract][Full Text] [Related]
19. X chromosome inactivation in fibroblasts of mentally retarded female carriers of the fragile site Xq27.3: application of the probe M27 beta to evaluate X inactivation status.
Schmidt M; Du Sart D; Kalitsis P; Fraser N; Leversha M; Voullaire L; Foster D; Davies J; Hills L; Petrovic V
Am J Med Genet; 1991; 38(2-3):411-5. PubMed ID: 1673316
[TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation.
Andreu N; Pujol-Moix N; Martinez-Lostao L; Oset M; Muñiz-Diaz E; Estivill X; Volpini V; Fillat C
Blood Cells Mol Dis; 2003; 31(3):332-7. PubMed ID: 14636648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
